SCHEMBL4728090

SCHEMBL4728090

S=C(Nc1cccc(Br)c1)NC1CCN(c2nncc3cc(Br)ccc23)CC1.S=C(Nc1ccccc1Br)NC1CCN(c2nncc3cc(Br)ccc23)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MAPK14 Q16539 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
KDM4E B2RXH2 1/20 0.38
RAB9A P51151 1/20 0.38
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA4 P22748 3/20 0.38
CA7 P43166 3/20 0.38
CA9 Q16790 3/20 0.38
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4583301 0.94 KMT2A (0.43) KMT2AMEN1ALDH1A1SMN1; SMN2MAPK14
SCHEMBL4584119 0.93 MAPK14 (0.44) KMT2ASMN1; SMN2MAPK14RAB9APKM
SCHEMBL4582502 0.89 KMT2A (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2MAPK14
SCHEMBL4727782 0.87 RAB9A (0.43) KMT2AALDH1A1MAPTMAPK1RAB9A
SCHEMBL4583084 0.87 KMT2A (0.43) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL4582586 0.86 KMT2A (0.50) KMT2AMEN1ALDH1A1SMN1; SMN2MAPK14
SCHEMBL4583868 0.86 KMT2A (0.41) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL4582544 0.86 KMT2A (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2MAPT
SCHEMBL4582792 0.85 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1SMN1; SMN2MAPK14
SCHEMBL4583306 0.85 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1SMN1; SMN2MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO claimed
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed